247 related articles for article (PubMed ID: 17359370)
1. Plasma microparticles and vascular disorders.
Lynch SF; Ludlam CA
Br J Haematol; 2007 Apr; 137(1):36-48. PubMed ID: 17359370
[TBL] [Abstract][Full Text] [Related]
2. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
3. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.
Amabile N; Guérin AP; Leroyer A; Mallat Z; Nguyen C; Boddaert J; London GM; Tedgui A; Boulanger CM
J Am Soc Nephrol; 2005 Nov; 16(11):3381-8. PubMed ID: 16192427
[TBL] [Abstract][Full Text] [Related]
4. Microparticles in vascular diseases.
George FD
Thromb Res; 2008; 122 Suppl 1():S55-9. PubMed ID: 18691501
[TBL] [Abstract][Full Text] [Related]
5. Circulating microparticles: pathophysiology and clinical implications.
Piccin A; Murphy WG; Smith OP
Blood Rev; 2007 May; 21(3):157-71. PubMed ID: 17118501
[TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions.
Akopov S; Sercombe R; Seylaz J
Cerebrovasc Brain Metab Rev; 1996; 8(1):11-94. PubMed ID: 9052980
[TBL] [Abstract][Full Text] [Related]
7. [Circulating endothelial microparticles: a new marker of vascular injury].
Boulanger CM; Leroyer AS; Amabile N; Tedgui A
Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
[TBL] [Abstract][Full Text] [Related]
8. [Cellular microparticles and blood-vessel damage. I. Structure, detection and origin].
Diamant M; Tushuizen ME; Sturk A; Nieuwland R
Ned Tijdschr Geneeskd; 2004 Jul; 148(28):1376-80. PubMed ID: 15291418
[TBL] [Abstract][Full Text] [Related]
9. The relevance of blood cell-vessel wall adhesive interactions for vascular thrombotic disease.
May AE; Neumann FJ; Preissner KT
Thromb Haemost; 1999 Aug; 82(2):962-70. PubMed ID: 10605810
[TBL] [Abstract][Full Text] [Related]
10. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques.
Leroyer AS; Isobe H; Lesèche G; Castier Y; Wassef M; Mallat Z; Binder BR; Tedgui A; Boulanger CM
J Am Coll Cardiol; 2007 Feb; 49(7):772-7. PubMed ID: 17306706
[TBL] [Abstract][Full Text] [Related]
11. [Microparticles and cardiovascular disease].
Morel O; Ohlmann P; Morel N; Jesel L; Bareiss P; Freyssinet JM; Toti F
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):226-35. PubMed ID: 15816326
[TBL] [Abstract][Full Text] [Related]
12. [Vascular disease and cellular activation: exploration of cell adhesion phenotype by quantitative flow cytometry].
Latger V; Dumas D; Lecompte T; Potron G; Stoltz JF
J Mal Vasc; 1999 Feb; 24(1):11-8. PubMed ID: 10192030
[TBL] [Abstract][Full Text] [Related]
13. [Cellular microparticles and blood-vessel damage. II. Functional characteristics and clinical significance].
Diamant M; Tushuizen ME; Sturk A; Nieuwland R
Ned Tijdschr Geneeskd; 2004 Jul; 148(28):1380-4. PubMed ID: 15291419
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms underlying the formation of circulating microparticles.
Morel O; Jesel L; Freyssinet JM; Toti F
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):15-26. PubMed ID: 21160064
[TBL] [Abstract][Full Text] [Related]
15. Cell-derived microparticles in haemostasis and vascular medicine.
Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A
Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection.
Morel O; Ohlmann P; Epailly E; Bakouboula B; Zobairi F; Jesel L; Meyer N; Chenard MP; Freyssinet JM; Bareiss P; Mazzucotelli JP; Toti F
J Heart Lung Transplant; 2008 Jan; 27(1):38-45. PubMed ID: 18187085
[TBL] [Abstract][Full Text] [Related]
17. Plasma thrombomodulin: new approach of endothelium damage.
Seigneur M; Dufourcq P; Conri C; Constans J; Mercie P; Pruvost A; Boisseau M
Int Angiol; 1993 Dec; 12(4):355-9. PubMed ID: 8207313
[TBL] [Abstract][Full Text] [Related]
18. Microparticles and type 2 diabetes.
Leroyer AS; Tedgui A; Boulanger CM
Diabetes Metab; 2008 Feb; 34 Suppl 1():S27-32. PubMed ID: 18358424
[TBL] [Abstract][Full Text] [Related]
19. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction.
Del Turco S; Basta G; Lazzerini G; Evangelista M; Rainaldi G; Tanganelli P; Christensen JH; Schmidt EB; De Caterina R
Haematologica; 2008 Jun; 93(6):892-9. PubMed ID: 18469350
[TBL] [Abstract][Full Text] [Related]
20. [Cell-derived microparticules: key players at the crossroad between inflammation and thrombosis].
Sabatier F; Lacroix R; Leroyer AS; Cointe S; Dignat-George F
Transfus Clin Biol; 2011 Apr; 18(2):62-9. PubMed ID: 21444231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
